Evidence map›Paper›PMID 41105412›Full record

Trial reportJAMA network open2025

Nutrition Info and Other Front-of-Package Labels and Simulated Food and Beverage Purchases: A Randomized Clinical Trial.

Anna H Grummon, Kevin O'Sullivan, Joshua Petimar, Cristina J Y Lee, Amanda B Zeitlin, Lauren P Cleveland, Caroline Collis, Aviva A Musicus, Verena Tiefenbeck, Elgar Fleisch and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06516627 (Online Randomized Experiment Evaluating Front-of-Package Nutrition Labeling Systems), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06516627 nacompletednot on this map

Online Randomized Experiment Evaluating Front-of-Package Nutrition Labeling Systems

TypeinterventionalSponsorHarvard Pilgrim Health CareRan2024 to 2024Enrolled5,638ConditionsNutrition, Food Selection, Food Preferences, Dietary HabitsArmsPositive Labels, Spectrum Labels, FDA High In Labels, FDA Traffic Light Labels
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anna H GrummonDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, California.
Kevin O'SullivanDepartment of Management, Technology, and Economics, ETH Zurich, Zurich, Switzerland.
Joshua PetimarDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Cristina J Y LeeDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, California.
Amanda B ZeitlinDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, California.
Lauren P ClevelandDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Caroline CollisDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Aviva A MusicusCenter for Science in the Public Interest, Washington, DC.
Verena TiefenbeckSchool of Business, Economics and Society, Friedrich-Alexander-Universität, Nürnberg, Germany.
Elgar FleischDepartment of Management, Technology, and Economics, ETH Zurich, Zurich, Switzerland.
Jason P BlockDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Funding

New Insights into the Federal Calorie Labeling LawR01DK115492 · NIDDK · HARVARD PILGRIM HEALTH CARE, INC. · PI Jason Perry Block · 2018 to 2026
$6.0M
NIDDK NIH HHS R01 DK115492
6 · The paper itself

Abstract

Importance: In January 2025, the US Food and Drug Administration (FDA) released a proposed rule to require front-of-package nutrition information (Nutrition Info) labels that would signal when packaged foods contain low, medium, or high levels of saturated fat, sodium, or added sugars (ie, nutrients of concern). However, it is unknown whether this labeling system would encourage healthier food and beverage purchases. Objectives: To test whether Nutrition Info labels similar to those proposed by the FDA could lead to healthier food and beverage purchases compared with other existing or proposed labeling systems. Design, Setting, and Participants: This randomized clinical trial was conducted online from October 31 to November 21, 2024. Participants included a national sample of US adults who reported being their household's primary shopper. Data were analyzed from November 26, 2024, to August 27, 2025. Intervention: Participants were randomized to exposure to 1 of 6 front-of-package labeling systems: positive labels (ie, labels that communicate only the positive attributes of a food) only, Nutrition Info labels (similar to the FDA's proposal), positive plus Nutrition Info labels, "High In" labels (similar to designs the FDA tested to signal when products contain high levels of nutrients of concern), positive plus High In labels, or spectrum labels (similar to designs used internationally rating products from least to most healthy). Main Outcomes and Measures: Participants shopped for foods and beverages in a large, simulated online grocery store. The primary outcome was healthfulness of participants' food and beverage selections, assessed using the United Kingdom's Ofcom Nutrient Profiling Model scores (ranging from 0 to 100, with higher scores indicating healthier choices). Scores were compared between groups using the average differential effect (ADE). Results: A total of 5636 participants completed the trial (3400 [60%] women; mean [SD] age, 40.3 [12.6] years). The spectrum labels led to healthier purchases compared with both the positive labels only (ADE, 2.42; 95% CI, 1.66-3.17; P < .001) and all other labeling systems (range of ADEs, -1.87 [95% CI, -2.63 to -1.11] to -2.45 [95% CI, -3.21 to -1.69]; P < .001). By contrast, the Nutrition Info, positive plus Nutrition Info, High In, and positive plus High In labels did not lead to healthier purchases compared with the positive labels only (range of ADEs, -0.04 [95% CI, -0.80 to 0.72; P = .92] to 0.54 [95% CI, -0.22 to 1.30; P = .16]). Label effects did not differ by nutrition literacy, household income, or educational attainment. Conclusions and Relevance: In this randomized clinical trial of food labeling systems, spectrum labels that rate foods from least to most healthy led to healthier purchases than positive labels and Nutrition Info labels similar to those proposed by the FDA. These findings suggest that spectrum labels may be more promising than both existing positive labels and the FDA's proposed labels for promoting healthier food purchases. Trial Registration: ClinicalTrials.gov Identifier: NCT06516627.

Indexed as

BeveragesConsumer BehaviorFood LabelingAdultFemaleHumansMaleMiddle AgedUnited StatesUnited States Food and Drug Administration

Identifiers

PMID41105412
PMCPMC12534843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.